Jaguar Animal Health, Inc. (JAGX) vs Longeveron Inc. (LGVN)
- Jaguar Animal Health, Inc. JAGX 2.04 −5.12%
- Longeveron Inc. LGVN 1.54 −3.14%
Jaguar Animal Health, Inc. and Longeveron Inc. are both Biotechnology companies. Longeveron Inc. is the larger, with a market value of $5.1M against $4.2M — 1.2× the size. Longeveron Inc. has negative trailing earnings, so its P/E is not meaningful; Jaguar Animal Health, Inc. trades at 0.0×. Jaguar Animal Health, Inc. grew revenue faster over the last twelve months: 135.5% against −42.7%. Jaguar Animal Health, Inc. has the higher net margin (−188.5% vs −1,977.6%) and the lower return on invested capital (−28,393.6% vs −4,549.0%). Across the 19 metrics below, Jaguar Animal Health, Inc. leads on 13 and Longeveron Inc. on 6.
Valuation
Profitability
| Metric | JAGX | LGVN | Biotechnology median |
|---|---|---|---|
| Gross margin | 82.31% | 69.76% | 65.77% |
| Operating margin | (93.10%) | (1,992.84%) | 0.00% |
| Net margin | (188.46%) | (1,977.59%) | 0.00% |
| Free cash flow margin | (24.03%) | (1,755.69%) | 0.00% |
| Return on equity | (1,125.38%) | (203.61%) | (54.09%) |
| Return on assets | (127.14%) | (145.64%) | (47.78%) |
| Return on invested capital | (28,393.64%) | (4,549.04%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack